Cell Therapeutics May Be Added To Russell 3000


Cell Therapeutics Inc. (Nasdaq: CTIC) is on the shortlist for possible addition to the Russell 3000 Index and the Russell Global Index lifting the stock price 20 cents to $1.63.

About this Entry

This page contains a single entry by published on June 15, 2009 7:43 AM.

Jazz Pharmaceuticals Reports Upbeat Trial Data was the previous entry in this blog.

Lear Downgraded is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12